D-Leucine 328-38-1 Leucine
The area of Chengdu Baishixing is 35,000 square metre ,
the staff members are 88,
our output value is over 120 millions per year.
Baishiying cooporates with Life Science Academy of Wuhan University to develop amino acids series products.We have professional science development and experiment ba-se station.
Our products are U.S.P.,AJI,EP(European Pharmacopoeia)standard.
CAS No.: | 328-38-1 | Other Names: | d-leucine | MF: | C6H13NO2 |
EINECS No.: | ********* | Place of Origin: | Sichuan China (Mainland) | Type: | Pharmaceutical Intermediates |
Purity: | 99.0% | Brand Name: | Chengdu Baishixing | Model Number: | 99.0% |
Application: | Pharmaceutical Intermediates | Appearance: |
White crystals or crystalline powder
|
Apprearance: |
White crystals or crystalline powder.
|
Name: | D-Leucine | CAS: | 328-38-1 |
Chengdu Baishixing Science and Technology Industry Co.,Ltd
(1)Year Establishment :2003
(2)Location: An national ecology example county in Pujiang, Chengdu,Sichuan Province.
(3)Main products:We have 5 series of products(protected amino acids,amino acids derivatives,peptides, plants amino acids and heterocycle chemical compounds) and over 80 kinds so far.Output is over 300 ton per year.
Specifications:
Mamufacture standard |
AJI97 |
Transmittance |
Not less than 95.0% |
Chloride |
Not more than 0.1% |
Heavy metals |
Not more than 10ppm |
Arsenic |
Not more than 2ppm |
Loss on drying |
Not more than 0.20% |
Residue on ignition |
Not more than 0.20% |
Chemical name |
D-2-Amino-4-methylpentanoic acid |
Molecular formula |
C6H13NO2 |
Molecular weight |
131.17 |
Assay |
98.0%~101.0% |
Application:
1. It can be used for peptide synthesis as biochemical reagents
2.It can be used as pharmaceutical intermediate
3.It can be used flife sciences
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View